Biopharma and med-tech companies raising money in public or private financings, including: Adlai Nortye, Medx, Polaryx, Salspera, Sangamo, Sonovascular, Vaxcyte.

New hires and promotions in the biopharma and med-tech industries, including: Aptevo, B. Braun, Bicycle, Bioivt, CDR-Life, Hemostemix, Immorta, Kupando, Kyverna, Leonabio, Metabolon, Pyxis, Rigel, Spruce, Valo, Zelluna.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aquestive, ARS, Astrazeneca, Cynosure Lutronic, Elevar, Exelixis, Galderma, GE, Incyte, Moonlake, Natera, OS Therapies, Pharming, Tuhura.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: 48Hour Discovery, Advancell, Alvotech, Affluent, Alvotech, Arctic Vision, Biotronik, Golden Age, Ipsen, Kahimmune, Lundbeck, MDCO, Micare Path, Newsoara, Origami, Personalis, Sandoz, Tenacia, Vtv.

Clinical updates for biopharma and med tech, including data readouts and publications: Arcutis, Guardant Health, Sanofi.

Biopharma and med-tech companies raising money in public or private financings, including: Affluent, Santé Ventures.

New hires and promotions in the biopharma and med-tech industries, including: Alterome, Neuroem, Nurexone, Quotient, Sparrow, Staar, Vent.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations in Asia-Pacific: Almirall, Bioarctic, Biogen, Drug Farm, Eisai, Huahui, Otsuka, Quoin.

Clinical updates from Asia-Pacific, including data readouts and publications: Innocare, Jyong, Kazia.

Biopharma happenings in Asia-Pacific including deals and partnerships, and other news in brief: Alps Group, Amgen, Bayer, BNC Korea, Boehringer Ingelheim, Chia Tai Feng Hai, Formation, Hanchorbio, Hanmi, Hetero Group, Insilico Medicine, Kyowa Kirin, Laboratorios Sanfer, Leios Therapeutics, Lisata, Mesoblast, MS Pharma, Poxel, Qilu, Regeneron, Samsung Bioepis, Simcere, Wuxi.